FibroBiologics Inc. Commo... (FBLG)
undefined
undefined%
At close: undefined
2.22
1.37%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue - - - -
Cost of Revenue 437.00K 94.00K - -
Gross Profit -437.00K -94.00K - -
Operating Income -8.89M -4.47M -1.58M -1.17M
Interest Income - - - -
Pretax Income -16.48M -5.12M -1.58M -1.17M
Net Income -16.48M -5.12M -1.58M -1.17M
Selling & General & Admin 6.52M 3.23M 1.06M 500.00K
Research & Development 2.37M 1.15M 521.00K 669.00K
Other Expenses - - - -
Operating Expenses 8.89M 4.37M 1.58M 1.17M
Interest Expense 147.00K 654.00K 4.00K -
Selling & Marketing Expenses 685.00K -94.00K - -
Cost & Expenses 8.89M 4.47M 1.58M 1.17M
Income Tax - - - -
Shares Outstanding (Basic) 32.49M 32.49M 32.49M 8.75M
Shares Outstanding (Diluted) 28.23M 32.49M 32.49M 8.75M
EPS (Basic) -0.59 -0.16 -0.05 -0.13
EPS (Diluted) -0.68 -0.16 -0.05 -0.13
EBITDA -15.90M -4.37M -1.58M -
Depreciation & Amortization 437.00K 94.00K - 1.17M